BioCentury
ARTICLE | Company News

Milligan, Martin leaving Gilead

July 26, 2018 1:05 AM UTC

Gilead Sciences Inc. (NASDAQ:GILD) said President and CEO John Milligan will step down at year end. The company's board is searching for a successor.

Milligan has been at Gilead for 28 years. He became CEO in March 2016 after serving as president since 2008 and COO since 2007. He was also CFO prior to that, and previously held positions in corporate development and project management...

BCIQ Company Profiles

Gilead Sciences Inc.